Transplant Outcomes of 9/10 HLA Matched Unrelated Donors (MUD) Treated with Post-Transplant Cyclophosphamide for Prevention of Graft Versus Host Disease

被引：1
|
作者：
Pingali, Sai Ravi [1 ]
Milton, Denai [1 ]
Popat, Uday R. [1 ]
Hosing, Chitra M. [1 ]
Bashir, Qaiser [1 ]
Alousi, Amin M. [1 ]
Jones, Roy [1 ]
Nieto, Yago [1 ]
Kebriaei, Partow [1 ]
Qazilbash, Muzaffar H. [1 ]
Andersson, Borje S. [1 ]
Shpall, Elizabeth J. [1 ]
Khouri, Issa F. [1 ]
Champlin, Richard E. [1 ]
Ciurea, Stefan O. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
BLOOD | 2014年 / 124卷 / 21期
关键词：
D O I：
10.1182/blood.V124.21.2486.2486
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Incidence of chronic graft versus host disease using post-transplant cyclophosphamide in HLA-matched versus haploidentical donors.
    Hitt, Mary Moses
    Yimer, Wondwosen
    Milner, Carter Payne
    Herrin, Vincent E.
    Elkins, Stephanie
    Bigelow, Carolyn L.
    Hilal, Talal
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [2] Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis Attenuates Disparity in Outcomes Between Use of Matched or Mismatched Unrelated Donors
    Shaffer, Brian C.
    Gooptu, Mahasweta
    Defor, Todd E.
    Maiers, Martin
    Bolanos-Meade, Javier
    Abboud, Ramzi
    Briggs, Adrienne D.
    Khimani, Farhad
    Modi, Dipenkumar
    Newcomb, Richard
    Shpall, Elizabeth J.
    Bupp, Caitrin
    Spellman, Stephen R.
    Stefanski, Heather E.
    Shaw, Bronwen E.
    Auletta, Jeffery J.
    Devine, Steven M.
    Jimenez, Antonio M. Jimenez
    Al Malki, Monzr M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (28)
  • [3] Short Course of Post-Transplant Cyclophosphamide and Bortezomib for the Prevention of Graft-Versus-Host-Disease after Matched Related or Unrelated Donor Blood or Marrow Transplant
    Al-Homsi, A. Samer
    Roy, Tara S.
    Cole, Kelli
    Bogema, Marlee
    Duffner, Ulrich
    Williams, Stephanie F.
    Mageed, Aly A.
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (02) : S322 - S322
  • [4] Post-transplant cyclophosphamide for graft-versus-host disease prophylaxis in HLA matched sibling or matched unrelated donor transplant for patients with acute leukemia, on behalf of ALWP-EBMT
    Annalisa Ruggeri
    Myriam Labopin
    Andrea Bacigalupo
    Boris Afanasyev
    Jan J. Cornelissen
    Ahmet Elmaagacli
    Maija Itälä-Remes
    Didier Blaise
    Ellen Meijer
    Yener Koc
    Noel Milpied
    Harry C. Schouten
    Nicolaus Kroeger
    Mohamad Mohty
    Arnon Nagler
    [J]. Journal of Hematology & Oncology, 11
  • [5] Post-transplant cyclophosphamide for graft-versus-host disease prophylaxis in HLA matched sibling or matched unrelated donor transplant for patients with acute leukemia, on behalf of ALWP-EBMT
    Ruggeri, Annalisa
    Labopin, Myriam
    Bacigalupo, Andrea
    Afanasyev, Boris
    Cornelissen, Jan J.
    Elmaagacli, Ahmet
    Itala-Remes, Maija
    Blaise, Didier
    Meijer, Ellen
    Koc, Yener
    Milpied, Noel
    Schouten, Harry C.
    Kroeger, Nicolaus
    Mohty, Mohamad
    Nagler, Arnon
    [J]. JOURNAL OF HEMATOLOGY & ONCOLOGY, 2018, 11
  • [6] Post-transplant cyclophosphamide as graft-versus-host disease prophylaxis in pediatric patients with hematologic malignancies transplanted from haploidentical and matched unrelated donors
    Abrosimov, A.
    Shelikhova, L.
    Shekhovtsova, Z.
    Skvortsova, J.
    Muzalevsky, I.
    Kazachenok, A.
    Ilushina, M.
    Shipitsina, I.
    Shasheleva, D.
    Khismatullina, R.
    Blagov, S.
    Gutovskaya, E.
    Myakova, N.
    Litvinov, D.
    Novichkova, G.
    Maschan, A.
    Maschan, M.
    [J]. BONE MARROW TRANSPLANTATION, 2016, 51 : S460 - S460
  • [7] POST-TRANSPLANT CYCLOPHOSPHAMIDE AS GRAFT-VERSUS-HOST DISEASE PROPHYLAXIS IN PEDIATRIC PATIENTS WITH HEMATOLOGIC MALIGNANCIES TRANSPLANTED FROM HAPLOIDENTICAL AND MATCHED UNRELATED DONORS
    Abrosimov, A.
    Shelikhova, L.
    Shekhovtsova, Z.
    Balashov, D.
    Skvortsova, Y.
    Kurnikova, E.
    Ilushina, M.
    Shipitsina, I.
    Shasheleva, D.
    Khismatullina, R.
    Gutovskaya, E.
    Blagov, S.
    Myakova, N.
    Litvinov, D.
    Baidildina, D.
    Novichkova, G.
    Maschan, M.
    Maschan, A.
    [J]. HAEMATOLOGICA, 2016, 101 : 636 - 636
  • [8] Post-Transplant High-Dose Cyclophosphamide for the Prevention of Graft-versus-Host Disease
    Al-Homsi, Ahmad Samer
    Roy, Tara S.
    Cole, Kelli
    Feng, Yuxin
    Duffner, Ulrich
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (04) : 604 - 611
  • [9] Post-transplant Cyclophosphamide versus Thymoglobulin in HLA-Mismatched Unrelated Donor Transplant
    Arai, Sally
    [J]. TRANSPLANTATION AND CELLULAR THERAPY, 2021, 27 (09): : 699 - 699
  • [10] Post-transplant cyclophosphamide as graft-versus-host disease prophylaxis (GvHD) in pediatric patients with acute lymphoid leukemia (ALL) transplanted from haploidentical and matched unrelated donors
    Abrosimov, A.
    Shelikhova, L.
    Shekhovtsova, Z.
    Starichkova, J.
    Balashov, D.
    Kurnikova, E.
    Ilyushina, M.
    Shipitsina, I.
    Shasheleva, D.
    Khismatullina, R.
    Gutovskaya, E.
    Blagov, S.
    Bogoyavlenskaya, A.
    Alyabieva, M.
    Radygina, S.
    Kozlovskaya, S.
    Mitrakov, K.
    Myakova, N.
    Litvinov, D.
    Novichkova, G.
    Maschan, M.
    Maschan, A.
    [J]. BONE MARROW TRANSPLANTATION, 2017, 52 : S374 - S374
12345